CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $264,622 | -19.1% | 14,227 | -44.2% | 0.08% | -42.1% |
Q3 2022 | $327,000 | +48.0% | 25,480 | -19.3% | 0.13% | +15.7% |
Q2 2022 | $221,000 | -37.0% | 31,571 | -25.4% | 0.12% | -1.7% |
Q1 2022 | $351,000 | -4.9% | 42,293 | -22.6% | 0.12% | +34.5% |
Q4 2021 | $369,000 | +27.7% | 54,618 | 0.0% | 0.09% | +26.1% |
Q3 2021 | $289,000 | -8.0% | 54,618 | 0.0% | 0.07% | +97.1% |
Q2 2021 | $314,000 | – | 54,618 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |